Importance of Early Weight Changes to Predict Long-Term Weight Gain During Psychotropic Drug Treatment

pROC: an open-source package for R and S+ to analyze and compare ROC curves

Xavier Robin, Natacha Turck, Alexandre Hainard et al. · BMC Bioinformatics · 2011 · 13.3K citations · Full text

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

Christoph U. Correll · JAMA · 2009 · 1K citations · Full text

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

Joost Dekker, David Wood, K.G. Kahl et al. · European Psychiatry · 2009 · 931 citations

Reduced Life Expectancy, Psychological Co-morbidities, Psychiatric Evaluation +22

Double-Blind Comparison of Olanzapine Versus Risperidone in the Treatment of Schizophrenia and Other Psychotic Disorders

Pierre V. Trân, S.H. Hamilton, Amy J. Kuntz et al. · Journal of Clinical Psychopharmacology · 1997 · 717 citations

Other Psychotic Disorders, Neuropsychology, Psychotropic Medication +19

A Behavioral Weight-Loss Intervention in Persons with Serious Mental Illness

Gail L. Daumit, Faith Dickerson, Nae Yuh Wang et al. · New England Journal of Medicine · 2013 · 517 citations · Full text